BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
BioTelemetry (BEAT) Tops Q2 EPS by 8c
July 30, 2019 4:11 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $111.8 million versus the consensus estimate of $111.11 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: Our growth momentum continued in the second quarter, with revenue growth of 10%, enabling us to achieve the high end of our guidance. This revenue growth was... More
